ZA89523B - Use of a benzamide - Google Patents
Use of a benzamideInfo
- Publication number
- ZA89523B ZA89523B ZA89523A ZA89523A ZA89523B ZA 89523 B ZA89523 B ZA 89523B ZA 89523 A ZA89523 A ZA 89523A ZA 89523 A ZA89523 A ZA 89523A ZA 89523 B ZA89523 B ZA 89523B
- Authority
- ZA
- South Africa
- Prior art keywords
- benzamide
- morpholinoethyl
- chloro
- treating
- new
- Prior art date
Links
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 title 2
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- YHXISWVBGDMDLQ-UHFFFAOYSA-N moclobemide Chemical compound C1=CC(Cl)=CC=C1C(=O)NCCN1CCOCC1 YHXISWVBGDMDLQ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH29888 | 1988-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA89523B true ZA89523B (en) | 1989-09-27 |
Family
ID=4183804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA89523A ZA89523B (en) | 1988-01-28 | 1989-01-23 | Use of a benzamide |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4906626A (da) |
| EP (1) | EP0326023B1 (da) |
| JP (1) | JPH07116043B2 (da) |
| KR (1) | KR960016203B1 (da) |
| AT (1) | ATE113207T1 (da) |
| AU (1) | AU620584B2 (da) |
| CA (1) | CA1332151C (da) |
| DE (1) | DE58908544D1 (da) |
| DK (1) | DK171094B1 (da) |
| ES (1) | ES2063060T3 (da) |
| HU (1) | HU203042B (da) |
| IE (1) | IE65409B1 (da) |
| IL (1) | IL89031A (da) |
| PH (1) | PH26030A (da) |
| ZA (1) | ZA89523B (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0551963A3 (en) * | 1986-12-17 | 1993-09-01 | Glaxo Group Limited | Use of heterocyclic derivatives for the manufacture of medicaments |
| FR2645742A1 (fr) * | 1989-04-12 | 1990-10-19 | Delagrange Laboratoires | Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive |
| JP3172202B2 (ja) * | 1990-11-29 | 2001-06-04 | エフ．ホフマン−ラ ロシュ アーゲー | 不安の障害の処置剤 |
| US6951884B2 (en) * | 2002-06-12 | 2005-10-04 | Hoffmann-La Roche Inc. | Fluorobenzamides and uses thereof |
| ATE411027T1 (de) * | 2003-10-23 | 2008-10-15 | Hoffmann La Roche | Benzazepin-derivate als mao-b-hemmer |
| EP1713486A4 (en) * | 2003-12-02 | 2009-04-29 | Sheldon Leslie James | COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY |
| EP2612854B1 (en) | 2005-10-25 | 2015-04-29 | Shionogi&Co., Ltd. | Aminothiazolidine and aminotetrahydrothiazepine derivatives as BACE 1 inhibitors |
| TW200902526A (en) * | 2007-04-24 | 2009-01-16 | Shionogi & Amp Co Ltd | Aminodihydrothiazin derivative substituted with a cyclic group |
| WO2008133273A1 (ja) | 2007-04-24 | 2008-11-06 | Shionogi & Co., Ltd. | アルツハイマー症治療用医薬組成物 |
| WO2009151098A1 (ja) * | 2008-06-13 | 2009-12-17 | 塩野義製薬株式会社 | βセクレターゼ阻害作用を有する含硫黄複素環誘導体 |
| JPWO2010047372A1 (ja) * | 2008-10-22 | 2012-03-22 | 塩野義製薬株式会社 | Ｂａｃｅ１阻害活性を有する２−アミノピリミジン−４−オンおよび２−アミノピリジン誘導体 |
| UA110467C2 (uk) | 2009-12-11 | 2016-01-12 | Шионогі Енд Ко., Лтд. | Похідні оксазину |
| EP2634188A4 (en) | 2010-10-29 | 2014-05-07 | Shionogi & Co | FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE |
| CN103261199A (zh) | 2010-10-29 | 2013-08-21 | 盐野义制药株式会社 | 萘啶衍生物 |
| WO2012147763A1 (ja) | 2011-04-26 | 2012-11-01 | 塩野義製薬株式会社 | オキサジン誘導体およびそれを含有するｂａｃｅ１阻害剤 |
| EP2912035A4 (en) | 2012-10-24 | 2016-06-15 | Shionogi & Co | DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY |
| ES2861520T3 (es) | 2016-04-12 | 2021-10-06 | E Vision Smart Optics Inc | Lentes electroactivas con puentes resistivos elevados |
| US10599006B2 (en) | 2016-04-12 | 2020-03-24 | E-Vision Smart Optics, Inc. | Electro-active lenses with raised resistive bridges |
-
1989
- 1989-01-11 CA CA000587927A patent/CA1332151C/en not_active Expired - Lifetime
- 1989-01-13 US US07/297,168 patent/US4906626A/en not_active Expired - Lifetime
- 1989-01-19 ES ES89100901T patent/ES2063060T3/es not_active Expired - Lifetime
- 1989-01-19 AT AT89100901T patent/ATE113207T1/de not_active IP Right Cessation
- 1989-01-19 DE DE58908544T patent/DE58908544D1/de not_active Expired - Lifetime
- 1989-01-19 EP EP89100901A patent/EP0326023B1/de not_active Expired - Lifetime
- 1989-01-23 IL IL8903189A patent/IL89031A/en unknown
- 1989-01-23 ZA ZA89523A patent/ZA89523B/xx unknown
- 1989-01-25 HU HU89303A patent/HU203042B/hu unknown
- 1989-01-25 JP JP1014249A patent/JPH07116043B2/ja not_active Expired - Lifetime
- 1989-01-27 DK DK036889A patent/DK171094B1/da not_active IP Right Cessation
- 1989-01-27 PH PH38119A patent/PH26030A/en unknown
- 1989-01-27 IE IE27389A patent/IE65409B1/en not_active IP Right Cessation
- 1989-01-27 KR KR1019890000867A patent/KR960016203B1/ko not_active Expired - Lifetime
- 1989-01-27 AU AU28836/89A patent/AU620584B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK36889D0 (da) | 1989-01-27 |
| IL89031A0 (en) | 1989-08-15 |
| KR890011589A (ko) | 1989-08-21 |
| HU203042B (en) | 1991-05-28 |
| IE890273L (en) | 1989-07-28 |
| PH26030A (en) | 1992-01-29 |
| AU620584B2 (en) | 1992-02-20 |
| JPH07116043B2 (ja) | 1995-12-13 |
| EP0326023A2 (de) | 1989-08-02 |
| AU2883689A (en) | 1989-08-03 |
| JPH01224318A (ja) | 1989-09-07 |
| EP0326023A3 (en) | 1990-09-05 |
| DK36889A (da) | 1989-07-29 |
| EP0326023B1 (de) | 1994-10-26 |
| HUT50042A (en) | 1989-12-28 |
| ATE113207T1 (de) | 1994-11-15 |
| IL89031A (en) | 1995-07-31 |
| IE65409B1 (en) | 1995-10-18 |
| DE58908544D1 (de) | 1994-12-01 |
| CA1332151C (en) | 1994-09-27 |
| KR960016203B1 (ko) | 1996-12-06 |
| DK171094B1 (da) | 1996-06-03 |
| US4906626A (en) | 1990-03-06 |
| ES2063060T3 (es) | 1995-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0326023A3 (en) | Benzamide against cognitive disorders | |
| EP0326034A3 (en) | Combination for the treatment of nervous cells and fibers illnesses and disorders | |
| GR3006001T3 (da) | ||
| EP0332356A3 (en) | Supply of carbon dioxide | |
| NO172627C (no) | Fremgangsmaate for fjernelse av hydrogensulfid med spesielle jernoksyder | |
| ZA878055B (en) | A therapeutically useful compound | |
| EP0305890A3 (en) | Use of bezafibrate for the treatment of diabetes | |
| ZA871062B (en) | Use of aromatic diamines for the treatment of angina and diamines therefor | |
| EP0243645A3 (en) | Compounds having a nootropic activity, agents containing them and their use in the treatment and prophylaxis of cognitive malfunctions | |
| EP0406211A3 (en) | Fucosidase inhibitors | |
| DE3879535D1 (da) | ||
| ZA886249B (en) | Use of a compound for the treatment of sleep disorders and depression | |
| IL89082A0 (en) | Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system | |
| EP0532629A4 (da) | ||
| EP0270782A3 (en) | Therapeutic agents for the prophylaxis of tumour metastasis | |
| DE3667109D1 (en) | Liquid for the treatment of a photoresist composition, and process therefor | |
| GR3004866T3 (da) | ||
| EP0271127A3 (en) | Use of guaifenesin in the treatment of urologic disorders | |
| EP0405376A3 (en) | Characterization of viruses | |
| ZA896334B (en) | Use of zofenopril for the treatment of rheumatoid arthritis | |
| DE3273177D1 (en) | Trans-dihyldrolisuride antipsychotic | |
| ES2044144T3 (es) | Nuevo procedimiento para la produccion de 4,6-dimetil-7-hidroxinonan-3-ona. | |
| AU8981891A (en) | Use of certain esters of hexahydro-8-hydroxy-2,6-methano- 2h-quinolizin-3(4h)-one and related compounds for treating cognitive disorders | |
| ZA893606B (en) | Use of diazepinones for treating disorders of the microcirculation | |
| JO1516B1 (en) | Compounds with cognitive effectiveness, factors containing them, and their use in treatment and disease prevention for cognitive dysfunction |